Randomized, Masked, Placebo-Controlled, Multicenter, Phase 3 Study of Batoclimab for Active, Moderate-To-Severe Thyroid Eye Disease

batoclimab (HBM9161) - Harbour BioMed, Immunovant, HanAll Biopharma

https://thyroid.joynmeeting.com/conference_hall/server/poster_schedule.php

George Kahaly; Antonio Manuel Garrido-Hermosilla; Annick Van Den Bruel; Daniel Briscoe; Michele Marino; Takahiro Hiraoka; Jonathan Janes; E Lin; Marius Stan

Sep 19, 2026